Latest News

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Chemours (CC) has quietly outperformed the broader materials sector over the past week, even though the stock is still down sharply over the past year, drawing value focused investors back for another look. See our latest analysis for Chemours. With the share price now at $12.96 and a 7 day share price return of 3.93 percent after a tough year to date decline of 22.44 percent, it looks like sentiment is stabilising rather than accelerating, especially given the 1 year total shareholder return...

Accenture (ACN) has quietly put together a steady rebound, with the stock up about 10% over the past month after a weak year to date. That move has investors revisiting its long term setup. See our latest analysis for Accenture. That recent pop in the share price, with a 7 day share price return of about 10 percent and a 30 day share price return close to 10 percent as well, has come after a tough stretch where year to date share price returns and 1 year total shareholder returns are still...

Snowflake (SNOW) just delivered a two-for-one update: a $200 million expansion of its Anthropic partnership to embed Claude powered AI agents across its data cloud, and fresh Q3 results with new guidance. See our latest analysis for Snowflake. Those moves have kept Snowflake’s share price on the front foot, with a roughly 19% 3 month share price return and a 42% 1 year total shareholder return suggesting momentum is still building rather than cooling off. If Snowflake’s AI push has your...

Kestra Medical Technologies (KMTS) has quietly delivered a sharp move, jumping about 12% in the latest session even as the stock remains down over the past month but up strongly over the past three months. See our latest analysis for Kestra Medical Technologies. That mix of a 12.21% one-day share price return and a softer 7-day share price return of minus 4.37 percent sits alongside a still impressive 51.88 percent 90-day share price return. This suggests medium-term momentum is building from...

Teledyne Technologies recently presented at the Goldman Sachs Industrials and Materials Conference 2025 in New York, with Vice Chairman Jason VanWees outlining the company’s latest developments for investors. The launch of its Xtium3 PCIe Gen4 frame grabber series highlights Teledyne’s push into higher-throughput industrial imaging, targeting demanding applications that rely on faster data acquisition and processing. Next, we’ll examine how the new Xtium3 PCIe Gen4 industrial imaging...

In recent months, Installed Building Products reported record Q3 net revenue and higher net income, announced a 150,000‑share repurchase under its ongoing buyback program, and received a first‑time BB+ long‑term issuer rating with a stable outlook from Fitch, alongside a #1 (Strong Buy) ranking from Zacks reflecting improved analyst sentiment. Together, these developments highlight a business generating strong cash flow with lender-validated balance sheet strength, while management actively...

Huntsman (HUN) has reduced its fourth quarter 2025 adjusted EBITDA outlook after an unplanned disruption at its Rotterdam polyurethanes plant, where the larger MDI production line is expected to remain offline until roughly mid December. See our latest analysis for Huntsman. The update comes after a sharp run, with a 1 month share price return of about 32 percent helping Huntsman claw back some ground despite a much weaker year to date picture and deeply negative multi year total shareholder...

Insulet stock reaction to recent performance Insulet (PODD) has quietly slipped over the past week and month, even though shares are still up solidly this year, making investors wonder whether the pullback is an opportunity or an early warning. See our latest analysis for Insulet. The recent softness, including a roughly 12% three-month share price return, sits against a near 20% year-to-date share price gain and a more modest one-year total shareholder return. This suggests momentum is...

Earlier in 2025, Hitachi Construction Machinery Co., Ltd. announced a minority investment in Rithmik Solutions as part of Rithmik’s latest financing round, aiming to combine its global equipment footprint with Rithmik’s real-time AI-powered analytics for smart mining. The move underlines Hitachi Construction Machinery’s push to build open digital platforms that can boost mining productivity while helping reduce environmental impact across operations. Next, we’ll examine how this AI-driven...

In November 2025, Gentex Corporation and The Genie Company announced an agreement to integrate Genie's Aladdin Connect platform into Gentex's HomeLink system, enabling vehicle-based and app-based control of smart-enabled garage doors via the HomeLink cloud. The partnership extends Gentex's connected-car and smart-home footprint by allowing many existing garage doors to become smart-enabled through Genie's retrofit kits, deepening Gentex's role at the intersection of vehicles and home...

CarMax (KMX) has quietly turned into a value puzzle for investors, with the stock sliding more than 50% over the past year even as annual net income edged higher. See our latest analysis for CarMax. That backdrop helps explain why, even with a modest 7 day share price return of 2.15 percent, CarMax’s 1 year total shareholder return of negative 53.34 percent signals sentiment and momentum are still firmly under pressure rather than turning. If CarMax’s slump has you reassessing the auto space,...

Rami Levi Chain Stores Hashikma Marketing 2006 (TASE:RMLI) just posted its Q3 and year to date numbers, with sales climbing but profits slipping, a mix that naturally sharpened investor focus on margins. See our latest analysis for Rami Levi Chain Stores Hashikma Marketing 2006. The latest earnings drop landed against a strong backdrop, with the share price up roughly 13 percent over three months and a robust 1 year total shareholder return near 48 percent, suggesting momentum is still...

Amphenol recently reported record third-quarter 2025 results, with sales rising very large year-on-year and adjusted earnings per share up sharply, largely driven by booming AI data center demand and a strong Communication Solutions segment, while also announcing a 52% increase in its quarterly dividend from January 2026. The company is further reshaping its business mix through aggressive acquisitions, including a pending US$10.50 billion purchase of CommScope’s Connectivity and Cable...

AMETEK, Inc. (AME) just gave investors a clear catalyst: a single-session 7.7% jump after its October 30 Q3 release, powered by double-digit gains in sales, orders, earnings, and better margins. See our latest analysis for AMETEK. That Q3 surge comes on top of a steady uptrend, with the share price up a solid double digit year to date and a strong multi year total shareholder return hinting that momentum is still building. If AMETEK’s move has you thinking about what else might be quietly...

ICL Group Ltd. recently announced a cash dividend of US$0.048 per share (about US$62,000,000 in total), payable on December 17, 2025, with varying Israeli withholding tax rates depending on shareholder residency and type. On top of this payout, an Israeli Supreme Court ruling now requires ICL to pay retroactive Dead Sea water extraction fees from 2018, adding US$70,000,000–US$90,000,000 in one-off costs and higher ongoing operating expenses through 2030. We will now examine how this new...

In late November and early December 2025, Eisai and Biogen reported new LEQEMBI (lecanemab) data at the CTAD conference, highlighting long-term “time savings” in Alzheimer’s progression and bioequivalent efficacy and safety for a newly approved subcutaneous maintenance formulation versus the existing intravenous regimen, alongside fresh biomarker evidence from cerebrospinal fluid studies. These findings suggest that earlier and continuous LEQEMBI treatment could meaningfully extend the time...

In early December 2025, Playtika asked investors to disregard a previously issued release announcing an NFL-themed collaboration for its World Series of Poker free-to-play app, saying the announcement was made in error or contained inaccuracies and offering no updated plans. The unusual step of retracting a high-profile NFL partnership announcement introduces fresh uncertainty around Playtika’s content pipeline, execution processes, and communication with investors. We’ll now look at how the...

SLB recently closed its US$7.80 billion acquisition of ChampionX and launched Tela, an AI assistant integrated across its energy technology platforms, while also declaring its next quarterly dividend and scheduling its fourth-quarter 2025 earnings call. Together, the ChampionX deal and Tela launch highlight SLB’s push to combine production optimization with digital tools and AI, potentially reshaping how the company serves energy operators globally. We’ll now examine how the launch of Tela...

ITT Inc. recently announced that its Board has appointed director Nazzic S. Keene to succeed Timothy H. Powers as non-executive Board Chair following his retirement, with the transition expected after her election at the May 2026 Annual Meeting of Shareholders. Keene’s background as former CEO of Science Applications International Corporation and her current board roles at Automatic Data Processing Inc. and Caterpillar Inc. adds deeper information technology and M&A integration expertise to...

Nelnet (NNI) has quietly rewarded patient investors, with the stock up about 26% year to date and more than doubling over five years, even as annual revenue recently dipped slightly. See our latest analysis for Nelnet. With the share price now at $133.18 and a year to date share price return of about 26 percent, momentum still looks constructive, while the five year total shareholder return of roughly 101 percent underlines how well the story has played out over time. If Nelnet's steady climb...

Soleno Therapeutics (SLNO) is back on traders’ radar after Wolfe Research launched coverage with a bullish stance, pushing back against short seller driven worries about its lead drug and recent launch stumbles. See our latest analysis for Soleno Therapeutics. The upbeat Wolfe call has helped steady sentiment after a bruising few months. The 1 day share price return of 5.41% has partially offset a 30 day share price return of minus 22.74%, while the three year total shareholder return of...

Air Lease (AL) has quietly pushed higher this year, and with the stock up roughly 34% year to date, investors are starting to revisit the leasing giant’s mix of growth, risk, and valuation. See our latest analysis for Air Lease. That climb in the share price to about $64.06 reflects a year of steadily improving sentiment, with a strong year to date share price return contrasting with gentler three and five year total shareholder returns. This suggests momentum has been building rather than...

While Renishaw plc ( LON:RSW ) might not have the largest market cap around , it saw a decent share price growth of 11...